RXMD Progressive Care Inc

Progressive Care Strengthens Management Team by Appointing Birute Norkute as COO

Progressive Care Strengthens Management Team by Appointing Birute Norkute as COO

MIAMI, FL, Jan. 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- () (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is very excited to announce the promotion and appointment of Birute Norkute as Chief Operating Officer (“COO”) of Progressive Care.

“Birute has been instrumental in every achievement PharmCo has had since its inception,” commented S. Parikh Mars, CEO of Progressive Care. “Her accomplishments to date have been stellar, and we see her unique and expansive skill set as invaluable in this new role given both our current needs and opportunities and the vision we have for the Company going forward. We are proud to promote diversity, and we welcome Ms. Norkute to the C-Suite quite simply because she is the single best person for the job.”

Birute Norkute has been a key part of the PharmCo team since 2008 and has been leading PharmCo operations since 2013. She stands out as the driving force behind a number of critical accomplishments. As the chief architect of the operational model for ensuring medication adherence, she successfully produced the Company’s consistent 5-star performance ratings in pharmacy dispensing and medication therapy management.

She has controlled budgetary compliance for PharmCo locations leading to efficiencies often superior to automated systems. She manages all IT infrastructure at the Company to ensure current protocols are in place for HIPAA compliance and technological efficiency. She has lead sales teams in the field and currently leads all operational staff at all pharmacy locations. 

In addition, Norkute has been the point person for all credentialing and contracting for all pharmacies and currently manages compliance and audit submissions. 

Mars continued, “Birute’s leadership in pharmacy credentialing, contracting, and compliance has resulted in all of our state licenses, our good standing with all PBMs and payors, our stellar audit performance (audit recoupments currently amount to less than 0.001% of revenues), and our top-tier national performance ratings, which have yielded maximum bonus payments on multiple occasions. In short, Birute is a rock star coming into this role.”

For more information about Progressive Care, please visit the company’s.

Connect and stay in touch with us on social media:

Progressive Care Inc.

PharmCo, LLC

Five Star RX

About Progressive Care Inc.

Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.

Cautionary Statement Regarding Forward-Looking Statements

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Investor Relations Contact:

Armen Karapetyan, Progressive Care

Senior Advisor Business Development



Public Relations Contact:

Caitlin Franscell, CMW Media



Web and Application Development Contact:

Marcello Jaspan, Mass Ventures Corp

EN
07/01/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Progressive Care Inc

 PRESS RELEASE

Progressive Care Inc. Announces Record Second Quarter 2023 Results wit...

Progressive Care Inc. Announces Record Second Quarter 2023 Results with Revenues of $11.6 Million and Gross Margins of 31% MIAMI, FL, Aug. 14, 2023 (GLOBE NEWSWIRE) -- via -- Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology provider, today announced financial results for the second quarter ended June 30, 2023. The Company experienced record quarterly revenues of $11.6 million, a 16% growth from the second quarter ended June 30, 2022. “Over the past few months, our team was focused on ensuring that Progressive ...

 PRESS RELEASE

Progressive Care Inc. Announces First Quarter 2023 Financial Results a...

Progressive Care Inc. Announces First Quarter 2023 Financial Results and Record Quarterly Revenues of $11.4 Million MIAMI, FL, May 12, 2023 (GLOBE NEWSWIRE) -- via -- ‍Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology provider, today announced financial results for the first quarter ended March 31, 2023. The Company experienced record quarterly revenues of $11.4 million, a 13% growth from the first quarter ended March 31, 2022. First Quarter 2023 Financial Highlights: Total pharmacy revenue increased...

 PRESS RELEASE

Progressive Care Inc. Announces Additional $1 Million Investment From ...

Progressive Care Inc. Announces Additional $1 Million Investment From NextPlat Corp. MIAMI, FL, May 11, 2023 (GLOBE NEWSWIRE) -- via – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology provider, today announced that it has successfully completed a transaction of $1 million investment from NextPlat Corp (NASDAQ: NXPL, NXPLW) (“NextPlat”), a global e-commerce provider. In connection with the $1 million investment, the Company sold to NextPlat 455,000 newly issued Units, with each Unit comprised of one share of th...

 PRESS RELEASE

Progressive Care Inc. Announces 2022 Annual Financial Results; $40.6 M...

Progressive Care Inc. Announces 2022 Annual Financial Results; $40.6 Million Total Revenue MIAMI, FL, April 03, 2023 (GLOBE NEWSWIRE) -- via – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology provider, today announced financial results for the year ended December 31, 2022. Total revenue increased to $40.6 million, a 5% growth from the prior year. 2022 Annual Financial Highlights (at or for the year ended December 31, 2022, as compared to at or for the year ended December 31, 2021): Total pharmacy revenue increas...

 PRESS RELEASE

Progressive Care, Inc. Announces Reverse Stock Split and Will Trade Un...

Progressive Care, Inc. Announces Reverse Stock Split and Will Trade Under Temporary Symbol RXMDD Miami, FL, Dec. 30, 2022 (GLOBE NEWSWIRE) -- via  Progressive Care Inc. (OTCQB: RXMD and RXMDD): Progressive Care Inc. (OTCQB: RXMD and RXMDD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, announced today that its Board of Directors approved a 1-for-200 reverse stock split of its common stock shares and that the common stock shares will begin trading on a split-adjusted basis at the commencement of trading on December 30, 2022. The com...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch